340B Provider Reforms Gaining Momentum In Congress
House Energy & Commerce Committee recommends more oversight of hospital participation in the 340B drug discount program.
You may also be interested in...
Missed Opportunities: 10 Questions We Wish Senators Had Asked At The Drug Pricing Hearing
Getting seven top pharma leaders in the same room, required to answer tough questions on drug pricing, is rare. Members of the Senate Finance Committee got that opportunity recently, but there are some questions our Pink Sheet reporters think they missed.
340B Reform: US House Bills Mark The End Of The Beginning
Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.
Many 340B Providers May Not Pass On Discounts Through Contract Pharmacies – GAO
House Energy and Commerce Committee releases US Government Accountability Office analysis of 340B contract pharmacies.